Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 5, 2024Theoretical and Natural ScienceOpen Access

Glucagon-like peptide-1 analogs for Alzheimers disease -- A systematic meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

CWCindy WangKYKailin Ye

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e75b23b6db6435876d20bfhttps://doi.org/10.54254/2753-8818/32/20240813
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer’s Disease2024 · 2 citations
  2. 2Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis2026
  3. 3Potential Role of GLP-1 Receptor Agonists for the Treatment of Alzheimer's Disease2025
  4. 4The Efficacy of Glucagon‐like Peptide‐1 Receptor Agonists on DifferentCognitive Domains: A Meta-analysis of Randomized Controlled Trials2026
  5. 5Liraglutide and Exenatide in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes2026